{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:26Z","timestamp":1761518786472},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/humrep\/dei322","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:24:55Z","timestamp":1128644695000},"page":"545-553","source":"Crossref","is-referenced-by-count":51,"title":["The ATAC (\u2018Arimidex\u2019, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment"],"prefix":"10.1093","volume":"21","author":[{"given":"S.","family":"Duffy","sequence":"first","affiliation":[]},{"given":"T.L.","family":"Jackson","sequence":"additional","affiliation":[]},{"given":"M.","family":"Lansdown","sequence":"additional","affiliation":[]},{"given":"K.","family":"Philips","sequence":"additional","affiliation":[]},{"given":"M.","family":"Wells","sequence":"additional","affiliation":[]},{"given":"S.","family":"Pollard","sequence":"additional","affiliation":[]},{"given":"G.","family":"Clack","sequence":"additional","affiliation":[]},{"given":"M.","family":"Coibion","sequence":"additional","affiliation":[]},{"given":"A.R.","family":"Bianco","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2005,10,6]]},"reference":[{"key":"key\n\t\t\t\t20171012151323_ANDIA-2000","doi-asserted-by":"crossref","unstructured":"Andia D , Lafuente P, Matorras R and Usandizaga JM (2000) Uterine side effects of treatment with tamoxifen. Eur J Obstet Gynecol Reprod Biol92,235\u2013240.","DOI":"10.1016\/S0301-2115(99)00291-2"},{"key":"key\n\t\t\t\t20171012151323_ATAC-2002","unstructured":"ATAC Trialists\u2019 Group (2002) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet359,2131\u20132139."},{"key":"key\n\t\t\t\t20171012151323_ATAC-2003","unstructured":"ATAC Trialists\u2019 Group (2003) Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: results of the ATAC (\u2018Arimidex\u2019, Tamoxifen, Alone or in Combination) trial efficacy and safety update analyses. Cancer98,1802\u20131810."},{"key":"key\n\t\t\t\t20171012151323_ATAC-2005","unstructured":"ATAC Trialists\u2019 Group (2005) Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years\u2019 adjuvant treatment for breast cancer. Lancet365,60\u201362."},{"key":"key\n\t\t\t\t20171012151323_BERAL-2002","doi-asserted-by":"crossref","unstructured":"Beral V , Banks E and Reeves G (2002) Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet360,942\u2013944.","DOI":"10.1016\/S0140-6736(02)11032-4"},{"key":"key\n\t\t\t\t20171012151323_BERGMAN-AND-BEELENML-2000","doi-asserted-by":"crossref","unstructured":"Bergman L , Beelen ML, Gallee MP, Hollema H, Benraadt J and van Leeuwen FE (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Lancet356,881\u2013887.","DOI":"10.1016\/S0140-6736(00)02677-5"},{"key":"key\n\t\t\t\t20171012151323_BONNETERRE-2000","doi-asserted-by":"crossref","unstructured":"Bonneterre J , Thurlimann B, Robertson JF, Krzakowski M, Mauriac L, Koralewski P, Vergote I, Webster A, Steinberg M and von Euler M (2000) Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the tamoxifen or Arimidex randomized group efficacy and tolerability study. J Clin Oncol18,3748\u20133757.","DOI":"10.1200\/JCO.2000.18.22.3748"},{"key":"key\n\t\t\t\t20171012151323_COHEN-AND-ROSENDJD-1994","doi-asserted-by":"crossref","unstructured":"Cohen I , Rosen DJD, Shapira J, Cordoba M, Gilboa S, Altaras MM, Yigael D and Beyth Y (1994) Endometrial changes with tamoxifen: comparison between tamoxifen-treatment and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol52,185\u2013190.","DOI":"10.1006\/gyno.1994.1029"},{"key":"key\n\t\t\t\t20171012151323_DECENSI-1996","doi-asserted-by":"crossref","unstructured":"Decensi A , Fontana V, Bruno S, Gustavino C, Gatteschi B and Costa A (1996) Effect of tamoxifen on endometrial proliferation. J Clin Oncol14,434\u2013440.","DOI":"10.1200\/JCO.1996.14.2.434"},{"key":"key\n\t\t\t\t20171012151323_DUFFY-2003","unstructured":"Duffy SR and Greenwood M (2003) The endometrial cancer data from the ATAC (\u2018Arimidex\u2019, Tamoxifen, Alone or in Combination) trial indicates a protective effect of anastrozole (\u2018Arimidex\u2019) upon the endometrium. Breast Cancer Res Treat82(Suppl 1), Abstract 134."},{"key":"key\n\t\t\t\t20171012151323_DUFFY-AND-JACKSONTL-2003","doi-asserted-by":"crossref","unstructured":"Duffy S , Jackson TL, Lansdown M, Philips K, Wells M, Pollard S, Clack G, Cuzick J, Coibion M and Bianco AR (2003) The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data. Br J Obstet Gynecol110,1099\u20131106.","DOI":"10.1111\/j.1471-0528.2003.02120.x"},{"key":"key\n\t\t\t\t20171012151323_EARLY-1998","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet351,1451\u20131467.","DOI":"10.1016\/S0140-6736(97)11423-4"},{"key":"key\n\t\t\t\t20171012151323_FORNANDER-AND-RUTQVISTLE-1989","doi-asserted-by":"crossref","unstructured":"Fornander T , Rutqvist LE, Cedermark B, Glas U, Mattsson A, Silfversward C, Skoog L, Somell A, Theve T, Wilking N et al (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1,117\u2013120.","DOI":"10.1016\/S0140-6736(89)91141-0"},{"key":"key\n\t\t\t\t20171012151323_GAMBACCIANI-2003","doi-asserted-by":"crossref","unstructured":"Gambacciani M , Monteleone P, Sacco A and Genazzani AR (2003) Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Best Pract Res Clin Endocrinol Metab17,139\u2013147.","DOI":"10.1016\/S1521-690X(02)00086-6"},{"key":"key\n\t\t\t\t20171012151323_ISMAIL-1994","doi-asserted-by":"crossref","unstructured":"Ismail SM (1994) Pathology of endometrium treated with tamoxifen. J Clin Pathol47,827\u2013833.","DOI":"10.1136\/jcp.47.9.827"},{"key":"key\n\t\t\t\t20171012151323_LINDAHL-1997","unstructured":"Lindahl B , Andolf E, Ingvar C, Liedman R, Ranstam J and Willen R (1997) Endometrial thickness and ovarian cysts as measured by ultrasound in asymptomatic postmenopausal breast cancer patients on various adjuvant treatments including tamoxifen. Anticancer Res17,3821\u20133824."},{"key":"key\n\t\t\t\t20171012151323_NABHOLTZ-2000","doi-asserted-by":"crossref","unstructured":"Nabholtz JM , Buzdar A, Pollak M, Harwin W, Burton G, Mangalik A, Steinberg M, Webster A and von Euler M (2000) Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. J Clin Oncol18,3758\u20133767.","DOI":"10.1200\/JCO.2000.18.22.3758"},{"key":"key\n\t\t\t\t20171012151323_NELSON-AND-HUMPHREYLL-2002","doi-asserted-by":"crossref","unstructured":"Nelson HD , Humphrey LL, Nygren P, Teutsch SM and Allan JD (2002) Postmenopausal hormone replacement therapy: scientific review. J Am Med Assoc288,872\u2013881.","DOI":"10.1001\/jama.288.7.872"},{"key":"key\n\t\t\t\t20171012151323_NEWCOMB-2003","doi-asserted-by":"crossref","unstructured":"Newcomb PA and Trentham-Dietz A (2003) Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States). Cancer Causes Control14,195\u2013201.","DOI":"10.1023\/A:1023066304473"},{"key":"key\n\t\t\t\t20171012151323_NUOVO-AND-NUOVOGJ-1989","doi-asserted-by":"crossref","unstructured":"Nuovo MA , Nuovo GJ, McCaffrey RM, Levine RU, Barron B and Winkler B (1989) Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol8,125\u2013131.","DOI":"10.1097\/00004347-198906000-00005"},{"key":"key\n\t\t\t\t20171012151323_RJE-2002","doi-asserted-by":"crossref","unstructured":"Rossouw JE , Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al; Writing Group for the Women\u2019s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. J Am Med Assoc288,321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"key\n\t\t\t\t20171012151323_SCHMIDT-2002","doi-asserted-by":"crossref","unstructured":"Schmidt T and Romer T (2002) Sonography and hysteroscopy for endometrial carcinoma and its precursors. Zentralbl Gynakol124,20\u201326.","DOI":"10.1055\/s-2002-20305"},{"key":"key\n\t\t\t\t20171012151323_WELNICKA-JASKIEWICZ-2003","doi-asserted-by":"crossref","unstructured":"Welnicka-Jaskiewicz M and Jassem J (2003) The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors. Cancer Treat Rev29,355\u2013361.","DOI":"10.1016\/S0305-7372(03)00067-7"},{"key":"key\n\t\t\t\t20171012151323_WICKERHAM-2002","doi-asserted-by":"crossref","unstructured":"Wickerham DL , Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L and Runowicz CD (2002) Association of tamoxifen and uterine sarcoma. J Clin Oncol20,2758\u20132760.","DOI":"10.1200\/JCO.2002.20.11.2758"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/21\/2\/545\/1691817\/dei322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T05:55:55Z","timestamp":1586498155000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/21\/2\/545\/613995\/The-ATAC-Arimidex-Tamoxifen-Alone-or-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,6]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,10,6]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dei322","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,10,6]]}}}